• Clinical Outcome of Patients with High-Risk Endometrial Carcinoma after Treatment with Chemotherapy only 

      Smogeli, Aud Elisabeth Farstad; Småstuen, Milada Cvancarova; Wang, Yun; Davidson, Ben; Kristensen, Gunnar S Balle; Lindemann, Kristina (International Journal of Gynecological Cancer;Volume 28, Issue 9, Journal article; Journal article; Peer reviewed, 2018-11-01)
      Objectives: Adjuvant treatment of high-risk endometrial cancer (EC) is still controversial. Several studies have tried to clarify the best treatment strategy, and guidelines have been made, but no study to date has shown ...
    • L1CAM as a prognostic marker in stage I endometrial cancer: A validation study 

      Smogeli, Aud Elisabeth Farstad; Davidson, Ben; Småstuen, Milada C; Holth, Arild; Katz, Betina; Risberg, Bjørn Åke; Kristensen, Gunnar S Balle; Lindemann, Kristina (Journal article; Peer reviewed, 2016)
      Background L1 cell adhesion molecule (L1CAM) overexpression has been reported to be strongly associated with poor prognosis in early stage endometrial cancer (EC). We aimed at the validation of L1CAM as a marker of ...
    • A national, prospective observational study of first recurrence after primary treatment for gynecological cancer in Norway 

      Vistad, Ingvild; Bjørge, Line; Popova, Olesya; Fiane, Bent; Sachse, Kurt; Tjugum, Ivar Jostein; Skrøppa, Siri; Bentzen, Anne Gry; Stokstad, Trine; Iversen, Grete Alræk; Salvesen, Helga Birgitte; Kristensen, Gunnar S Balle; Dørum, Anne (Acta Obstetricia et Gynecologica Scandinavica;96(10), Journal article; Peer reviewed, 2017-08-10)
      INTRODUCTION: Gynecological cancer patients are routinely followed up for five years after primary treatment. However, the value of such follow up has been debated, as retrospective studies indicate that first recurrence ...